Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Edesa Biotech Inc diskutieren

Edesa Biotech Inc

WKN: A2PL1Q / Symbol: EDSA / Name: Edesa Biotech / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /

0,39 €
-28,77 %

Einschätzung Buy
Rendite (%) -60,91 %
Kursziel 15,12
Veränderung
Endet am 15.03.24

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 54,12
Veränderung
Endet am 12.10.24

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at Brookline Capital Management. They now have a $57.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 9,17
Veränderung
Endet am 22.11.24

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 19,13
Veränderung
Endet am 29.11.24

Edesa Biotech, Inc. (NASDAQ: EDSA) had its price target lowered by analysts at HC Wainwright from $70.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for EDSA provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 19,61
Veränderung
Endet am 14.02.25

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 19,61
Veränderung
Endet am 28.06.25

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 18,92
Veränderung
Endet am 20.08.25

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat